The Corrections

watched an eleven-inning Phillies game and listened to his phone ring every ten minutes, every five minutes, every two minutes, he’d understood that at the ticking heart of Caroline was a desperate insecurity. Sooner or later, if he withheld his love, she came knocking on his chest with her little fist and let him have his way.
    Caroline showed no sign of weakening, however. Late at night, when Gary was too freaked out and angry to shut his eyes, let alone sleep, she politely but firmly declined to fight with him. She was particularly adamant in her refusal to discuss Christmas; she said that listening to Gary on the topic was like watching an alcoholic drink.
    “What do you need from me?” Gary asked her. “Tell me what you need to hear from me.”
    “I need you to take responsibility for your mental health.”
    “Jesus, Caroline. Wrong, wrong, wrong answer.”
    Meanwhile Discordia, the goddess of marital strife, had pulled strings with the airline industry. There appeared in the Inquirer a full-page ad for a slasheroo sale on Midland Airlines tickets, including a $198 round-trip fare between Philly and St. Jude. Only four dates in late December were blacked out; by staying just one extra day at Christmastime Gary could take the whole family to and from St. Jude (nonstop!) for under a thousand bucks. He had his travel agent hold five tickets for him, renewing the option daily. Finally, on Friday morning, with the sale due to end at midnight, he’d announced to Caroline that he was buying tickets. In accordance with her strict no-Christmas policy, Caroline turned to Aaron and asked him if he’d studied for his Spanish test. From his office at Cen Trust, in a spirit of trench warfare, Gary called his travel agent and authorized the purchase. Then he called his doctor and requested a sleep aid, a short-term prescription, something a little more potent than the nonprescription stuff. Dr. Pierce replied that a sleep aid didn’t sound like such a good idea. Caroline, Pierce said, had mentioned that Gary might be depressed, and a sleep aid certainly wasn’t going to help with that . Maybe, instead, Gary would like to come in and talk about how he was feeling?
    For a moment, after he hung up, Gary let himself imagine being divorced. But three glowing and idealized mental portraits of his children, shadowed by a batlike horde of fears regarding finances, chased the notion from his head.
    At a dinner party on Saturday he’d rifled the medicine chest of his friends Drew and Jamie, hoping to find a bottle of something in the Valium class, but no such luck.
    Yesterday Denise had called him and insisted, with ominous steeliness, that he have lunch with her. She said she’d seen Enid and Alfred in New York on Saturday. She said that Chip and his girlfriend had flaked on her and vanished.
    Gary, lying awake last night, had wondered if stunts likethis were what Caroline meant when she described Chip as a man “honest enough” to say what he could and couldn’t “tolerate.”
    “The cells are genetically reprogrammed to release nerve-growth factor only when locally activated!” Earl Eberle’s video facsimile said cheerfully.
    A fetching young model, her skull in an Eberle Helmet, was strapped into a machine that retrained her brain to instruct her legs to walk.
    A model wearing a wintry look, a look of misanthropy and sourness, pushed up the corners of her mouth with her fingers while magnified cutaway animation revealed, within her brain, the flowering of dendrites, the forging of new synaptic links. In a moment she was able to smile, tentatively, without using her fingers. In another moment, her smile was dazzling.
CORECKTALL: IT’S THE FUTURE!
    “The Axon Corporation is fortunate to hold five U.S. patents protecting this powerful platform technology,” Earl Eberle told the camera. “These patents, and eight others that are pending, form an insurmountable fire wall protecting the hundred-fifty million dollars that we have spent to date on research and development. Axon is the recognized world leader in this field. We have a six-year track record of positive cash flows and a revenue stream that we expect to top eighty million dollars in the coming year. Potential investors may rest assured that every penny of every dollar we raise on December 15 will be spent on developing this marvelous and potentially historic product.
    “Corecktall: It’s the Future!” Eberle said.
    “It’s the Future!” intoned the